Omnicell Inc. (OMCL)
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?
Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Omnicell (OMCL) Q1 Earnings and Revenues Surpass Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.26 per share a year ago.
Should You Continue to Hold OMCL Stock in Your Portfolio?
Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Omnicell (OMCL) Q4 Earnings Lag Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy
Omnicell (OMCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?
Reasons to Add Omnicell Stock to Your Portfolio Right Now
OMCL's expanding SaaS pipeline, global push and solid solvency highlight growth potential despite rising competition.
